Bosentan FDA Link

A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.

Also Known As:

Tracleer; 4- t- Butyl- N- (6- (2- hydroxyethoxy)- 5- (2- methoxyphenoxy)- 2,2'- bipyrimidin- 4- yl)benzenesulfonamide; Bosentan Anhydrous; Bosentan Monohydrate; Ro 47-0203; Ro-47-0203; Ro 47 0203; Ro 470203; Benzenesulfonamide, 4- (1,1- dimethylethyl)- N- (6- (2- hydroxyethoxy)- 5- (2- methoxyphenoxy)(2,2'- bipyrimidin)- 4- yl)-

Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - Benzenesulfonamides: 153
      - Bosentan: 1230
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzenesulfonamides: 153
        Bosentan: 1230
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - Bosentan: 1230
      - Benzenesulfonamides: 153
        Bosentan: 1230
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Bosentan: 1230

M Cimillio Selected Research

M Cimillio Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure